The site of the lesion was confirmed through a left sided abdominothoracic incision, and the carcinoma was resected and an oesophagogastric anastomosis performed. She made an uninterrupted recovery and was discharged on the 22nd day after operation. Histological examination of the tumour showed squamous cell carcinoma.
Over the years I had regular news of the patient both from herself and from her family doctor. She had no recurrence of her dysphagia.
In May 1978 her son wrote to the hospital to say that his mother had just died at the age of 85 "as a result of a stroke." I Torek, F, 3tournal of the American Medical Association, 1913 , 60, 1533 . (Accepted 31 August 1978 Hammersmith Hospital, London W12 OHS R H FRANKLIN, CBE, FRCS, honorary visiting surgeon
Atenolol and metoprolol in mild hypertension
We report the findings of a study of the cardioselective P-adrenoceptor antagonists atenolol and metoprolol in the treatment of patients with mild hypertension.
Patients, methods, and results
The procedure we followed has been described.1 I The protocol excluded patients whose lying diastolic pressure fell below 90 mm Hg after a four-week outpatient run-in period on a matching placebo. A double-blind cross-over method was then used to assess the effects of four treatments each provided by identical-looking capsules and given twice daily at 8 am and 6 pm for a four-week period: (1) atenolol 100 mg, (2) atenolol 200 mg, (3) metoprolol 100 mg, and (4) metoprolol 200 mg. The order of administration was determined by a random code and each patient received all four treatments. Four-week wash-out periods on matching placebo were included between the active treatment periods.
Blood pressures were recorded by Hawksley random-zero sphygmomanometers (diastolic pressure phase 4) under standard conditions.1 2 The mean of two or three blood pressure readings after three to five minutes lying and two to three minutes standing was recorded. A single measurement of pulse and blood pressure was taken immediately after completion of a predetermined exercise load.' 2 The observer not recording the blood pressure completed in another room a separate questionnaire on symptoms. Questions covered volunteered information and included specific items about general wellbeing, dizziness, headaches, energy, tiredness, mood, sleep, dreams, and bowel habit. An analysis of variance was used to examine the non-active treatment periods. After testing for overall differences (F test) Student's t test was used on adjusted means to look at differences between pairs. An analysis of covariance was used to examine the active treatments, fitting the immediately preceding non-active treatment as the covariate. F tests and t tests were performed as above. The trial was analysed on information from 20 patients (11 men) aged 31-58 (mean 45 6) years with a mean initial weight of 70 3 kg (range 54-93 kg). Capsule counts were satisfactory throughout (>90 %).
The run-in, treatment, and wash-out period means of blood pressure, pulse, and weight are shown in the table. The mean lying and standing blood pressures after the four-week run-in period on placebo were 156/101 and 151/106 mm Hg. The reduction in the mean lying and standing blood pressure for both doses of atenolol and metoprolol was approximately 16/14 mm Hg. There was no significant difference in hypotensive effect or effect on pulse rates or weight between atenolol and metoprolol at either dose after four weeks' treatment. All treatment periods were significantly superior to the run-in and wash-out periods. No sequence effects were seen when the non-treatment periods were examined. No differences were found between the results obtained for the first and second fortnights of the wash-out periods. Analysis of reported side effects showed similar patterns throughout the active and non-treatment periods. Further details of the analysis may be obtained from NPB.
Comment
This study shows that atenolol and metoprolol act equally in reducing raised blood pressure levels in the dosage range studied (200 and 400 mg/day). We have previously shown that increasing the dose of atenolol does not significantly increase any hypotensive effect in doses of 50, 100, and 200 mg once daily3; 200 or 400 mg/day given as two doses2; or 150 or 300 mg day given in three doses.4 A similar lack of increased hypotensive effect appears to hold also for metoprolol in the range 200 and 400 mg/day. -i84 :_±6-9 ±5-8 164 ±62~5-9 ±3-9 ±7-0 ±6.5 ±5-1 ±5-5 ±6-8 ±5.0 ±:-5. 22~2-1 ±-:2-3 ±27 ± 19 ±2-0 ±-2-4 ± 2-4 ±2.1 ±-4 ±2 5 ±26 ±-4 ±25 ±i2-7 ±2-3 ±2-0 ±2-5 ±2-4 ±2-6 ±2-6 ±2-6 ±2-7 ±2-7 ±2-6 ±2-7 + 2-7 ±2-6 ±2-7 ±2-6 ±2-6 ±2-7 ±2-5
